Pliant Therapeutics Inc (PLRX)

$1.31 +0.02 (1.55%)
Market Cap 81.73M
Revenue (ttm) 0.00
Net Income (ttm) -210.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.15
Volume 826,191
Avg Vol 1,268,992
Day's Range N/A - N/A
Shares Out 61.45M
Stochastic %K 50%
Beta 1.36
Analysts Hold
Price Target $2.78

Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonal...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 481 6770
Address:
331 Oyster Point Boulevard, South San Francisco, United States
ACInvestorBlog
ACInvestorBlog Jan. 13 at 8:51 PM
$PLRX i have been accumulating this cash rich bio name.... trading at bargain prices.
2 · Reply
Bwill15
Bwill15 Jan. 13 at 5:13 PM
$PLRX 225M cash on hand, paid off all debt Oct 25, trading at 1/3 cash. No trading volume, stagnant price action. Need some news of team at some point. Would enjoy seeing them buy a late stage molecule and give their pipeline some life. Accumulating non stop during these times.
0 · Reply
sandman7473
sandman7473 Jan. 10 at 12:48 AM
$PLRX 1.30 support now?
0 · Reply
Cledson40
Cledson40 Jan. 9 at 5:52 PM
$PLRX beautiful
0 · Reply
tsingyuanTemp
tsingyuanTemp Jan. 9 at 2:54 PM
$PLRX Tang stays pretty long in this one. They need to come out with a plan ASAP.
0 · Reply
Bwill15
Bwill15 Jan. 8 at 4:07 PM
$PLRX honestly has very little pipeline that is so early in development…really only playing the fact it’s trading at 1/3 cash on hand for a swing
0 · Reply
Rohtan
Rohtan Jan. 8 at 3:45 PM
$PLRX too good to ignore this one. Overdue for a mega run
0 · Reply
Gunnar1
Gunnar1 Jan. 8 at 3:12 PM
$PLRX Added some shares...
0 · Reply
Lyn30
Lyn30 Jan. 8 at 2:32 AM
$PLRX Slowly showing some strength
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 7 at 3:52 PM
$PLRX breaks abv $1.35 on volume..... can get wild !! Keep in mind, they have a net cash of $3 per share..... in other words, the stock is trading for FREE.....
0 · Reply
Latest News on PLRX
Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

Dec 4, 2025, 1:53 PM EST - 5 weeks ago

Pliant Cancer Drug Boosts Responses When Paired With Merck's Blockbuster Keytruda In Tough-To-Treat Tumors

MRK

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Dec 4, 2025, 7:30 AM EST - 5 weeks ago

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

Dec 1, 2025, 8:30 AM EST - 6 weeks ago

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 2 months ago

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 5 months ago

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Pliant Therapeutics Provides Update on BEACON-IPF

Jun 27, 2025, 4:05 PM EDT - 7 months ago

Pliant Therapeutics Provides Update on BEACON-IPF

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

May 21, 2025, 4:03 PM EDT - 8 months ago

Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 8 months ago

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

May 1, 2025, 4:05 PM EDT - 9 months ago

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Apr 7, 2025, 4:05 PM EDT - 10 months ago

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference

Pliant Therapeutics: An Activist On Deck

Apr 3, 2025, 12:22 PM EDT - 10 months ago

Pliant Therapeutics: An Activist On Deck

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Mar 17, 2025, 8:00 AM EDT - 10 months ago

Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 13, 2025, 11:04 AM EDT - 10 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

Mar 13, 2025, 7:20 AM EDT - 10 months ago

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Mar 3, 2025, 4:05 PM EST - 11 months ago

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder

Mar 3, 2025, 1:32 PM EST - 11 months ago

Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Mar 3, 2025, 9:27 AM EST - 11 months ago

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 11 months ago

The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation

Feb 27, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Connect

Feb 26, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Reach Out

Feb 25, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pliant Therapeutics, Inc. (PLRX) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Shareholders to Learn More About the Investigation

Feb 24, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Shareholders to Learn More About the Investigation

Pliant Therapeutics, Inc. (PLRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 11 months ago

Pliant Therapeutics, Inc. (PLRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Connect

Feb 21, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pliant Therapeutics, Inc. (PLRX) And Encourages Investors to Connect

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Feb 20, 2025, 3:39 PM EST - 11 months ago

PLRX Investors Have Opportunity to Join Pliant Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Stockholders to Inquire about Securities Investigation

Feb 20, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Pliant Therapeutics, Inc. (PLRX) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Investors to Learn More About the Investigation

Feb 19, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Stockholders to Learn More About the Investigation

Feb 18, 2025, 10:00 AM EST - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pliant Therapeutics, Inc. (PLRX) and Encourages Stockholders to Learn More About the Investigation

ACInvestorBlog
ACInvestorBlog Jan. 13 at 8:51 PM
$PLRX i have been accumulating this cash rich bio name.... trading at bargain prices.
2 · Reply
Bwill15
Bwill15 Jan. 13 at 5:13 PM
$PLRX 225M cash on hand, paid off all debt Oct 25, trading at 1/3 cash. No trading volume, stagnant price action. Need some news of team at some point. Would enjoy seeing them buy a late stage molecule and give their pipeline some life. Accumulating non stop during these times.
0 · Reply
sandman7473
sandman7473 Jan. 10 at 12:48 AM
$PLRX 1.30 support now?
0 · Reply
Cledson40
Cledson40 Jan. 9 at 5:52 PM
$PLRX beautiful
0 · Reply
tsingyuanTemp
tsingyuanTemp Jan. 9 at 2:54 PM
$PLRX Tang stays pretty long in this one. They need to come out with a plan ASAP.
0 · Reply
Bwill15
Bwill15 Jan. 8 at 4:07 PM
$PLRX honestly has very little pipeline that is so early in development…really only playing the fact it’s trading at 1/3 cash on hand for a swing
0 · Reply
Rohtan
Rohtan Jan. 8 at 3:45 PM
$PLRX too good to ignore this one. Overdue for a mega run
0 · Reply
Gunnar1
Gunnar1 Jan. 8 at 3:12 PM
$PLRX Added some shares...
0 · Reply
Lyn30
Lyn30 Jan. 8 at 2:32 AM
$PLRX Slowly showing some strength
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 7 at 3:52 PM
$PLRX breaks abv $1.35 on volume..... can get wild !! Keep in mind, they have a net cash of $3 per share..... in other words, the stock is trading for FREE.....
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 7 at 3:15 PM
$PLRX Daily time-frame.
0 · Reply
pc247cz
pc247cz Jan. 7 at 3:02 PM
$PLRX watching 👀
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 7 at 3:01 PM
$PLRX at breakout point. Could explode higher over 1.35 !!
0 · Reply
mangingriskandcandles
mangingriskandcandles Jan. 6 at 9:12 PM
$PLRX I expected a higher move up today, buying was driving it up last sessions but now long shadow upward showed sellers still won’t let this go more selling then buying.
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 8:49 PM
$PLRX Volume accumulation today. Just needs to break and close abv 1.35 in the coming sessions for a big rally. This undervalued small bio name has a net cash of $3 per share, so is just a matter of time.... or not... todays volume could be a signal
0 · Reply
Rohtan
Rohtan Jan. 6 at 5:40 PM
$PLRX added more at 1.27 . Waiting patiently for explosion
0 · Reply
sandman7473
sandman7473 Jan. 6 at 5:24 PM
$PLRX nice fade
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 3:08 PM
$PLRX nearly 1M shares traded in the first 30 minutes of trading. The average daily trading volume for PLRX stock over the last 30 days (approximately 4 weeks, covering trading days from December 7, 2025, to January 6, 2026) is approximately 951,478 shares. FOLLOW THE FLOW !!!
1 · Reply
Lyn30
Lyn30 Jan. 6 at 2:43 PM
$PLRX Yesterday who sold me good chunk now crying 😂
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 2:40 PM
$PLRX 1.67 next pivot level.... LFG !!!! +$3 per share in cash !
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 6 at 2:36 PM
$PLRX big volume pop
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 5 at 10:03 PM
$KALA sometimes we just need to be greedy when the others are fearful 😉 patience always paysoff 🤑 the same will happen with $PLRX and VTGN accumulate and relax.... the market will adjust the fundamentals.... you must understand that big boys need to buy a ton first.
0 · Reply